Validating biomarkers for brain health in diverse populations

Multiethnic Validation of VCID biomarkers in South Texas

NIH-funded research University of Texas Hlth Science Center · NIH-10925408

This study is looking for ways to find early signs of brain health issues related to small vessel disease, which can affect memory and thinking, and it's inviting people from South Texas, especially Hispanic and African American communities, to help us discover better ways to prevent and treat dementia.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Science Center NIH-funded
Lab location1 site (San Antonio, United States)
Project IDNIH-10925408 on NIH RePORTER

What this research studies

This research focuses on identifying and validating biomarkers related to cerebral small vessel disease (CSVD), which is linked to cognitive impairment and dementia. The study aims to recruit a diverse population from South Texas, including Hispanic and African American individuals, to ensure that the findings are applicable to various ethnic groups. By utilizing data from stroke and dementia clinics, as well as population studies, the research seeks to develop reliable biomarkers that can help in the prevention and treatment of dementia. Participants will contribute to a comprehensive analysis that could lead to significant advancements in understanding brain health.

Who could benefit from this research

Good fit: Ideal candidates for this research include Hispanic and African American individuals who are at risk for or experiencing cognitive impairment or dementia.

Not a fit: Patients who do not belong to the targeted ethnic groups or who do not have concerns related to cognitive impairment or dementia may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic tools and treatment strategies for dementia, particularly in diverse populations.

How similar studies have performed: Previous research has shown promise in validating biomarkers for cognitive impairment, but this study aims to expand on those findings by focusing on a multiethnic population, making it a novel approach.

Where this research is happening

San Antonio, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.